Adial Pharmaceuticals, Inc. (ADIL)
Total Valuation
ADIL has a market cap or net worth of $2.27 million. The enterprise value is $1.95 million.
| Market Cap | 2.27M |
| Enterprise Value | 1.95M |
Important Dates
The last earnings date was Tuesday, November 14, 2023, after market close.
| Earnings Date | Nov 14, 2023 |
| Ex-Dividend Date | n/a |
Share Statistics
ADIL has 1.22 million shares outstanding. The number of shares has increased by 14.53% in one year.
| Shares Outstanding | 1.22M |
| Shares Change (YoY) | +14.53% |
| Shares Change (QoQ) | +4.16% |
| Owned by Insiders (%) | 13.39% |
| Owned by Institutions (%) | 4.71% |
| Float | 1.05M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.97 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.15, with zero debt.
| Current Ratio | 2.15 |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -234.10% and return on invested capital (ROIC) is -384.57%.
| Return on Equity (ROE) | -234.10% |
| Return on Assets (ROA) | -149.10% |
| Return on Capital (ROIC) | -384.57% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$379,356 |
| Employee Count | 16 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -502 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -65.44% in the last 52 weeks. The beta is 1.06, so ADIL's price volatility has been similar to the market average.
| Beta (1Y) | 1.06 |
| 52-Week Price Change | -65.44% |
| 50-Day Moving Average | 2.03 |
| 200-Day Moving Average | 4.99 |
| Relative Strength Index (RSI) | 47.19 |
| Average Volume (30 Days) | 78,483 |
Short Selling Information
The latest short interest is 25,790, so 2.12% of the outstanding shares have been sold short.
| Short Interest | 25,790 |
| Short Previous Month | 41,217 |
| Short % of Shares Out | 2.12% |
| Short % of Float | 2.45% |
| Short Ratio (days to cover) | 0.21 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -9.00M |
| Pretax Income | -6.07M |
| Net Income | -6.07M |
| EBITDA | -6.05M |
| EBIT | -6.07M |
| Earnings Per Share (EPS) | -$5.72 |
Balance Sheet
The company has $315,880 in cash and no debt, giving a net cash position of $315,880 or $0.26 per share.
| Cash & Cash Equivalents | 315,880 |
| Total Debt | n/a |
| Net Cash | 315,880 |
| Net Cash Per Share | $0.26 |
| Equity / Book Value | 2.34M |
| Book Value Per Share | 1.92 |
| Working Capital | 607,307 |
Cash Flow
| Operating Cash Flow | -7.34M |
| Capital Expenditures | n/a |
| Free Cash Flow | -7.34M |
| FCF Per Share | -$6.22 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ADIL does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Earnings Yield | -267.93% |
| FCF Yield | -323.78% |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -14.53% |
| Shareholder Yield | -14.53% |
Analyst Forecast
The average price target for ADIL is $150.00, which is 7,964.52% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $150.00 |
| Price Target Difference | 7,964.52% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on August 7, 2023. It was a reverse split with a ratio of 1:25.
| Last Split Date | Aug 7, 2023 |
| Split Type | Reverse |
| Split Ratio | 1:25 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |